NEW YORK (GenomeWeb) – Nightingale Health and UK Biobank unveiled plans today to analyze metabolic biomarkers in 500,000 blood samples.

The project, which is expected to take 30 months, will focus on metabolic biomarkers previous research has linked to heart disease, type 2 diabetes, and other common chronic diseases. It will use Nightingale's NMR-based metabolite profiling platform, which the company said is able to measure more than 200 metabolites per blood sample.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.